In Vitro Synergistic Antimicrobial Effect of Imipenem and Colistin Against an Isolate of Multidrug-resistant Enterobacter cloacae

Kuan Hung Lin, Yin Ching Chuang, Shih Hui Lee, Wen Liang Yu

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background/Purpose: Enterobacter cloacae is an important nosocomial pathogen responsible for various infections. Little is known about the synergistic effects of imipenem and colistin against multidrug-resistant E. cloacae. Therefore, we investigated the in vitro effects of imipenem and colistin against a clinical isolate of multidrug-resistant E. cloacae. Methods: A strain of E. cloacae, designed Ent 831, was isolated from the sputum of a woman who developed severe pneumonia in a medical intensive care unit. Minimal inhibitory concentrations (MICs) of imipenem and colistin were determined by the agar dilution method. The synergistic effects were investigated using the time-kill method. Results: MICs of imipenem and colistin for E. cloacae strain Ent 831 were 0.5 μg/mL and 1.0 μg/mL, respectively. Using a standard ino culum (5 × 105) CFU/mL), synergism was shown with a concentration of two times the MICs of imipenem and colistin. Furthermore, four times the MIC of imipenem completely inhibited bacterial growth for more than 48 hours, but four times the MICs of colistin resulted in re-growth after 4 hours. There was no synergism between imipenem and colistin at two times the MICs against a high concentration inoculum (6.24 × 106) CFU/mL). Nevertheless, imipenem, with or without colistin, at a concentration of four times MICs could inhibit the growth of bacteria for more than 48 hours. Conclusion: High-dose imipenem, alone or in combination with colistin, is effective against multidrug-resistant E. cloacae. Colistin alone, even at a high dose, is not effective. However, in vitro susceptibility to antimicrobial compounds does not always correlate with clinical success. Thus further testing of these antibiotic combinations in animal models is needed in order to predict their suitability for clinical use.

Original languageEnglish
Pages (from-to)317-322
Number of pages6
JournalJournal of Microbiology, Immunology and Infection
Volume43
Issue number4
DOIs
Publication statusPublished - Aug 2010

Fingerprint

Colistin
Enterobacter cloacae
Imipenem
Growth
In Vitro Techniques
Sputum
Agar
Intensive Care Units
Pneumonia
Animal Models
Anti-Bacterial Agents
Bacteria

Keywords

  • Colistin
  • Enterobacter cloacae
  • Imipenem
  • Minimal inhibitory concentrations
  • Time-kill study

ASJC Scopus subject areas

  • Microbiology (medical)
  • Immunology and Allergy
  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Medicine(all)

Cite this

In Vitro Synergistic Antimicrobial Effect of Imipenem and Colistin Against an Isolate of Multidrug-resistant Enterobacter cloacae. / Lin, Kuan Hung; Chuang, Yin Ching; Lee, Shih Hui; Yu, Wen Liang.

In: Journal of Microbiology, Immunology and Infection, Vol. 43, No. 4, 08.2010, p. 317-322.

Research output: Contribution to journalArticle

@article{f76855b385af42a495d6bfef4c217b23,
title = "In Vitro Synergistic Antimicrobial Effect of Imipenem and Colistin Against an Isolate of Multidrug-resistant Enterobacter cloacae",
abstract = "Background/Purpose: Enterobacter cloacae is an important nosocomial pathogen responsible for various infections. Little is known about the synergistic effects of imipenem and colistin against multidrug-resistant E. cloacae. Therefore, we investigated the in vitro effects of imipenem and colistin against a clinical isolate of multidrug-resistant E. cloacae. Methods: A strain of E. cloacae, designed Ent 831, was isolated from the sputum of a woman who developed severe pneumonia in a medical intensive care unit. Minimal inhibitory concentrations (MICs) of imipenem and colistin were determined by the agar dilution method. The synergistic effects were investigated using the time-kill method. Results: MICs of imipenem and colistin for E. cloacae strain Ent 831 were 0.5 μg/mL and 1.0 μg/mL, respectively. Using a standard ino culum (5 × 105) CFU/mL), synergism was shown with a concentration of two times the MICs of imipenem and colistin. Furthermore, four times the MIC of imipenem completely inhibited bacterial growth for more than 48 hours, but four times the MICs of colistin resulted in re-growth after 4 hours. There was no synergism between imipenem and colistin at two times the MICs against a high concentration inoculum (6.24 × 106) CFU/mL). Nevertheless, imipenem, with or without colistin, at a concentration of four times MICs could inhibit the growth of bacteria for more than 48 hours. Conclusion: High-dose imipenem, alone or in combination with colistin, is effective against multidrug-resistant E. cloacae. Colistin alone, even at a high dose, is not effective. However, in vitro susceptibility to antimicrobial compounds does not always correlate with clinical success. Thus further testing of these antibiotic combinations in animal models is needed in order to predict their suitability for clinical use.",
keywords = "Colistin, Enterobacter cloacae, Imipenem, Minimal inhibitory concentrations, Time-kill study",
author = "Lin, {Kuan Hung} and Chuang, {Yin Ching} and Lee, {Shih Hui} and Yu, {Wen Liang}",
year = "2010",
month = "8",
doi = "10.1016/S1684-1182(10)60049-7",
language = "English",
volume = "43",
pages = "317--322",
journal = "Journal of Microbiology, Immunology and Infection",
issn = "0253-2662",
publisher = "Elsevier Taiwan LLC",
number = "4",

}

TY - JOUR

T1 - In Vitro Synergistic Antimicrobial Effect of Imipenem and Colistin Against an Isolate of Multidrug-resistant Enterobacter cloacae

AU - Lin, Kuan Hung

AU - Chuang, Yin Ching

AU - Lee, Shih Hui

AU - Yu, Wen Liang

PY - 2010/8

Y1 - 2010/8

N2 - Background/Purpose: Enterobacter cloacae is an important nosocomial pathogen responsible for various infections. Little is known about the synergistic effects of imipenem and colistin against multidrug-resistant E. cloacae. Therefore, we investigated the in vitro effects of imipenem and colistin against a clinical isolate of multidrug-resistant E. cloacae. Methods: A strain of E. cloacae, designed Ent 831, was isolated from the sputum of a woman who developed severe pneumonia in a medical intensive care unit. Minimal inhibitory concentrations (MICs) of imipenem and colistin were determined by the agar dilution method. The synergistic effects were investigated using the time-kill method. Results: MICs of imipenem and colistin for E. cloacae strain Ent 831 were 0.5 μg/mL and 1.0 μg/mL, respectively. Using a standard ino culum (5 × 105) CFU/mL), synergism was shown with a concentration of two times the MICs of imipenem and colistin. Furthermore, four times the MIC of imipenem completely inhibited bacterial growth for more than 48 hours, but four times the MICs of colistin resulted in re-growth after 4 hours. There was no synergism between imipenem and colistin at two times the MICs against a high concentration inoculum (6.24 × 106) CFU/mL). Nevertheless, imipenem, with or without colistin, at a concentration of four times MICs could inhibit the growth of bacteria for more than 48 hours. Conclusion: High-dose imipenem, alone or in combination with colistin, is effective against multidrug-resistant E. cloacae. Colistin alone, even at a high dose, is not effective. However, in vitro susceptibility to antimicrobial compounds does not always correlate with clinical success. Thus further testing of these antibiotic combinations in animal models is needed in order to predict their suitability for clinical use.

AB - Background/Purpose: Enterobacter cloacae is an important nosocomial pathogen responsible for various infections. Little is known about the synergistic effects of imipenem and colistin against multidrug-resistant E. cloacae. Therefore, we investigated the in vitro effects of imipenem and colistin against a clinical isolate of multidrug-resistant E. cloacae. Methods: A strain of E. cloacae, designed Ent 831, was isolated from the sputum of a woman who developed severe pneumonia in a medical intensive care unit. Minimal inhibitory concentrations (MICs) of imipenem and colistin were determined by the agar dilution method. The synergistic effects were investigated using the time-kill method. Results: MICs of imipenem and colistin for E. cloacae strain Ent 831 were 0.5 μg/mL and 1.0 μg/mL, respectively. Using a standard ino culum (5 × 105) CFU/mL), synergism was shown with a concentration of two times the MICs of imipenem and colistin. Furthermore, four times the MIC of imipenem completely inhibited bacterial growth for more than 48 hours, but four times the MICs of colistin resulted in re-growth after 4 hours. There was no synergism between imipenem and colistin at two times the MICs against a high concentration inoculum (6.24 × 106) CFU/mL). Nevertheless, imipenem, with or without colistin, at a concentration of four times MICs could inhibit the growth of bacteria for more than 48 hours. Conclusion: High-dose imipenem, alone or in combination with colistin, is effective against multidrug-resistant E. cloacae. Colistin alone, even at a high dose, is not effective. However, in vitro susceptibility to antimicrobial compounds does not always correlate with clinical success. Thus further testing of these antibiotic combinations in animal models is needed in order to predict their suitability for clinical use.

KW - Colistin

KW - Enterobacter cloacae

KW - Imipenem

KW - Minimal inhibitory concentrations

KW - Time-kill study

UR - http://www.scopus.com/inward/record.url?scp=77955331009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955331009&partnerID=8YFLogxK

U2 - 10.1016/S1684-1182(10)60049-7

DO - 10.1016/S1684-1182(10)60049-7

M3 - Article

VL - 43

SP - 317

EP - 322

JO - Journal of Microbiology, Immunology and Infection

JF - Journal of Microbiology, Immunology and Infection

SN - 0253-2662

IS - 4

ER -